KAVIGALE
KAVIGALE
Approved
DIN Number
02556332
Drug Class
Human
Market Date
N/A
Company
HC
astrazeneca canada inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02556332
AIG Number0166644001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
,
Schedule D
A
ATC Code
J06BD09 SIPAVIBART
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
,
Intramuscular
AHFS Classification08:18.24
Health Canada Classification
ACTIVE INGREDIENTS (1)
SIPAVIBARTActive
Strength: 150 MG / ML
Monograph: SIPAVIBART